I
21.20
0.36 (1.73%)
| Previous Close | 20.84 |
| Volume | 715,395 |
| Price / Earnings (Forward) | 8.82 |
| Price / Sales | 4.02 |
| Price / Book | 1.22 |
| 52 Weeks Range |
| Profit Margin | -16.15% |
| Operating Margin (TTM) | 47.02% |
| Diluted EPS (TTM) | -0.950 |
| Quarterly Revenue Growth (YOY) | 14.40% |
| Quarterly Earnings Growth (YOY) | -67.00% |
| Total Debt/Equity (MRQ) | 80.23% |
| Current Ratio (MRQ) | 2.48 |
| Operating Cash Flow (TTM) | 200.26 M |
| Levered Free Cash Flow (TTM) | 153.81 M |
| Return on Assets (TTM) | 9.40% |
| Return on Equity (TTM) | -8.84% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | Innoviva, Inc. | Mixed | Bearish |
AIStockmoo Score
1.3
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | 2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -0.5 |
| Average | 1.25 |
|
Innoviva Inc is a company with a portfolio of royalties and innovative healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Core |
| % Held by Insiders | 0.98% |
| % Held by Institutions | 110.22% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Systematic Financial Management Lp | 30 Jun 2026 | 2,023,565 |
| Sarissa Capital Management Lp | 30 Jun 2026 | 1,890,604 |
No data within this time range.
No data within this time range.
| 5Y Average Dividend Yield | 0.00% |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 08 Sep 2015 | 29 Jul 2015 | 30 Sep 2015 | 0.25 Cash |
| 10 Jun 2015 | - | 30 Jun 2015 | 0.25 Cash |
| 10 Mar 2015 | 23 Feb 2015 | 31 Mar 2015 | 0.25 Cash |
| 21 Nov 2014 | 16 Oct 2014 | 23 Dec 2014 | 0.25 Cash |
| 26 Aug 2014 | 06 Aug 2014 | 18 Sep 2014 | 0.25 Cash |
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2015 | 0.750 | 3 | 7.12 |
| 2014 | 0.500 | 2 | 3.53 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |